DSC2 and cardiomyopathy: Functional, structural and expression analyses of the DSC2 transgenic mice revealed cardiomyocyte necrosis, an acute inflammatory process, ECM remodeling and fibrotic replacement leading to decreased cardiac function and cardiomyopathy.